Company: BNBX
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001410578-25-001814
Chunk: 2

Company: BNB PLUS CORP.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1F
Chunk 2
---
 320,000Total liabilities​  2,946,702​  3,820,955​​​​​​​Commitments and contingencies (Note G)​   ​   ​​​​​​​Applied DNA Sciences, Inc. stockholders’ equity:​   ​   Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30, 2025 and September 30, 2024​  —​  —Series A Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of June 30, 2025 and September 30, 2024​  —​  —Series B Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of June 30, 2025 and September 30, 2024​  —​  —​​​ ​​​​Common stock, par value $0.001 per share; 200,000,000 shares authorized as of June 30, 2025 and September 30, 2024; 901,500 and 13,755 shares issued and outstanding as of June 30, 2025 and September 30, 2024, respectively​  902​  14Additional paid in capital ​  381,150,267​  318,815,358Accumulated deficit ​  (373,888,601)​  (309,672,755)Applied DNA Sciences, Inc. stockholders’ equity​  7,262,568​  9,142,617Noncontrolling interest​​ (274,524)​​ (174,532)Total equity​​ 6,988,044​​ 8,968,085 ​​​​​​​Total liabilities and equity​$ 9,934,746​$ 12,789,040

​

See the accompanying notes to the unaudited condensed consolidated financial statements

​